resected bile duct cancer
Conditions
Interventions
GEM+CDDP study
Sponsors
Dokkyo Medical Uniiversity
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Bile duct cancer, pathological diagnosis as adenocarcinoma including adenoaquamous cell carcinoma, Stage is I-IV and R 0-1 resection. 2)Patients never had chemo-radiation therapy. 3) registration within 10 week after operation. 4)PS is 0-1 5)Good oral intake 6)no ascites and distance metastasis 7)clear of age limited 8)pass the criteria as below Hb 3000/mm3, WBC 3000/mm3, Plt 10,000/mm3 AST,ALT 150IU/L, T-Bli 3.0mg.dl, Cr 1.2mg/dl, 9) get informed consent
Exclusion criteria
Exclusion criteria: 1)Recurrence before registration 2)evidence of ascites and pleural effusion. 3)Evidence of cardiac effusion 4)Patients have pneumonia or pleural fibrosis. 5)Uncontrolled diarrhea 6)No evidence of OMI 3 months before registration. 7) No viral hepatitis 8)Uncontrolled DM 9)No BTF 2 week before registration. 10)There are not complication, such as cardiac, renal failure and/or liver failure, peptic ulcer, bowel pararitic disorder and stable for mental status. 11)no allergy. 12)No evidence of other organ malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| disease free survival | — |
Countries
Japan,Asia(except Japan),North America
Contacts
Public ContactMitsugi Shimoda
Dokkyo Medical Uniiversity Second department of Surgey
Outcome results
None listed